LifeStance Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	9.66	-57.44	-186.26	-215.56	-307.2
Depreciation & Amortization	54.75	70.95	80.44	69.2	54.14
Other Amortization	1.02	1.67	2.1	1.95	1.8
Stock-Based Compensation	74.7	76.17	99.39	187.43	259.44
Other Operating Activities	46.36	43.28	21.18	26.71	-0.9
Change in Accounts Receivable	36.09	-6.4	-24.18	-21.66	-24.21
Change in Accounts Payable	-1.56	0.5	-5.61	7.67	0.62
Change in Other Net Operating Assets	-74.87	-21.47	-3.94	-2.94	25.73
Operating Cash Flow	146.15	107.26	-16.88	52.79	9.42
Operating Cash Flow Growth	36.26%	-	-	460.39%	-
Capital Expenditures	-36.13	-21.57	-40.52	-79.26	-94.49
Cash Acquisitions	-	-	-19.82	-60.21	-99.58
Investing Cash Flow	-36.13	-21.57	-60.34	-139.46	-194.08
Long-Term Debt Issued	-	287.81	57.75	257.32	98.8
Long-Term Debt Repaid	-7.25	-289.49	-2.47	-189.38	-320.21
Net Debt Issued (Repaid)	-7.25	-1.69	55.28	67.95	-221.41
Issuance of Common Stock	-	-	-	-	549.91
Repurchase of Common Stock	-8.71	-	-	-0.9	-
Other Financing Activities	-	-8.26	-7.86	-19.78	-14.64
Financing Cash Flow	-15.96	-9.95	47.43	47.26	313.86
Net Cash Flow	94.07	75.75	-29.8	-39.41	129.2
Free Cash Flow	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	28.39%	-	-	-	-
Free Cash Flow Margin	7.72%	6.85%	-5.44%	-3.08%	-12.75%
Free Cash Flow Per Share	0.28	0.23	-0.16	-0.07	-0.26
Cash Income Tax Paid	1.57	0.06	0.08	2.24	1.09
Levered Free Cash Flow	112.9	100.28	48.48	51.65	1.42
Unlevered Free Cash Flow	119.17	115.2	59.64	62.16	23.94
Change in Working Capital	-40.34	-27.37	-33.72	-16.94	2.14

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q